High-risk human papillomavirus infection and p16INK4a protein expression in laryngeal lesions

Pathology Research and Practice

Volumn 204, Issue 8, 2008, Pages 545-552

  Laco, Jan ^a   Slaninka, Igor ^a   Jirásek, Michal ^a   Čelakovský, Petr ^a   Vošmiková, Hana ^a   Ryška, Aleš ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

CISH; HPV; Larynx; p16 protein; PCR

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; VIRUS DNA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARCINOGENESIS; CHILD; CONTROLLED STUDY; DYSPLASIA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFECTION RISK; LARYNX CARCINOMA; LARYNX DISORDER; LARYNX PAPILLOMATOSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; VIRUS INFECTION; VOCAL CORD DISORDER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHAPAPILLOMAVIRUS; CARCINOMA; CHILD; CHILD, PRESCHOOL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA PROBES, HPV; DNA, VIRAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFANT; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; PAPILLOMA; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; SENSITIVITY AND SPECIFICITY;

EID: 47149084932     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2008.03.001     Document Type: Article

References (39)

1. Abramson A.L., Nouri M., Mullooly V., Fisch G., and Steinberg B.M. Latent human papillomavirus infection is comparable in the larynx and trachea. J. Med. Virol. 72 (2004) 473-477
2. Almadori G., Cadoni G., Cattani P., Galli J., Bussu F., Ferrandina G., Scambia G., Fadda G., and Maurizzi M. Human papillomavirus infection and epidermal growth factor receptor expression in primary laryngeal squamous cell carcinoma. Clin. Cancer Res. 7 (2001) 3988-3993
3. Arndt O., Johannes A., Zeise K., and Brock J. High-risk HPV types in oral and laryngeal papilloma and leukoplakia. Laryngorhinootologie 76 (1997) 142-149
4. Badaracco G., Venuti A., Morello R., Muller A., and Marcante M.L. Human papillomavirus in head and neck carcinomas: prevalence, physical status and relationship with clinical/pathological parameters. Anticancer Res. 20 (2000) 1301-1305
5. Balukova O.V., Shcherbak L.N., Savelov N.A., Ungiadze G.V., and Zborovskaia I.B. Papilloma virus infection in pretumor and tumor masses of the larynx. Vestn. Ross. Akad. Med. Nauk 12 (2004) 36-39
6. Brandsma J.L., and Abramson A.L. Association of papillomavirus with cancers of the head and neck. Arch. Otolaryngol. Head Neck Surg. 115 (1989) 621-625
7. Brink A.A., Snijders P.J., and Meijer C.J. HPV detection methods. Dis. Markers 23 (2007) 273-281
8. DiLorenzo T.P., and Steinberg B.M. Differential regulation of human papillomavirus type 6 and 11 early promoters in cultured cells derived from laryngeal papillomas. J. Virol. 69 (1995) 6865-6872
9. Dosemeci M., Gokmen I., Unsal M., Hayes R.B., and Blair A. Tobacco, alcohol use, and risks of laryngeal and lung cancer by subsite and histologic type in Turkey. Cancer Causes Control 8 (1997) 729-737
10. Franceschi S., Munoz N., Bosch X.F., Snijders P.J., and Walboomers J.M. Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence. Cancer Epidemiol. Biomarkers Prev. 5 (1996) 567-575
11. Gillison M.L., Koch W.M., Capone R.B., Spafford M., Westra W.H., Wu L., Zahurak M.L., Daniel R.W., Viglione M., Symer D.E., Shah K.V., and Sidransky D. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 92 (2000) 709-720
12. Herrero R., Castellsague X., Pawlita M., Lissowska J., Kee F., Balaram P., Rajkumar T., Sridhar H., Rose B., Pintos J., Fernandez L., Idris A., Sanchez M.J., Nieto A., Talamini R., Tavani A., Bosch F.X., Reidel U., Snijders P.J., Meijer C.J., Viscidi R., Munoz N., and Franceschi S. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J. Natl. Cancer Inst. 95 (2003) 1772-1783
13. Huang C.C., Qiu J.T., Kashima M.L., Kurman R.J., and Wu T.C. Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method. Mod. Pathol. 11 (1998) 971-977
14. Hubbard R.A. Human papillomavirus testing methods. Arch. Pathol. Lab. Med. 127 (2003) 940-945
15. Kashima H.K., Mounts P., and Shah K. Recurrent respiratory papillomatosis. Obstet. Gynecol. Clin. North Am. 23 (1996) 699-706
16. Kaya H., Kotiloglu E., Inanli S., Ekicioglu G., Bozkurt S.U., Tutkun A., and Kullu S. Prevalence of human papillomavirus (HPV) DNA in larynx and lung carcinomas. Pathologica 93 (2001) 531-534
17. INK4a as a specific marker for dysplasia and neoplastic epithelial cells of the cervix uteri. Int. J. Cancer 92 (2001) 276-284
18. Krecicki T., Smigiel R., Fraczek M., Kowalczyk M., and Sasiadek M.M. Studies of the cell cycle regulatory proteins P16, cyclin D1 and retinoblastoma protein in laryngeal carcinoma tissue. J. Laryngol. Otol. 118 (2004) 676-680
19. Kreimer A.R., Clifford G.M., Boyle P., and Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 467-475
20. Lin K.Y., Westra W.H., Kashima H.K., Mounts P., and Wu T.C. Coinfection of HPV-11 and HPV-16 in a case of laryngeal squamous papillomas with severe dysplasia. Laryngoscope 107 (1997) 942-947
21. Major T., Szarka K., Sziklai I., Gergely L., and Czegledy J. The characteristics of human papillomavirus DNA in head and neck cancers and papillomas. J. Clin. Pathol. 58 (2005) 51-55
22. Michaels L., and Hellquist H.B. Ear, Nose and Throat Histopathology (2001), Springer-Verlag, London pp. 345-346
23. Monk B.J., Cook N., Ahn C., Vasilev S.A., Berman M.L., and Wilczynski S.P. Comparison of the polymerase chain reaction and Southern blot analysis in detecting and typing human papilloma virus deoxyribonucleic acid in tumors of the lower female genital tract. Diagn. Mol. Pathol. 3 (1994) 283-291
24. Mounts P., Shah K.V., and Kashima H. Viral etiology of juvenile- and adult-onset squamous papilloma of the larynx. Proc. Natl. Acad. Sci. USA 79 (1982) 5425-5429
25. Park J.S., Hwang E.S., Park S.N., Ahn H.K., Um S.J., Kim C.J., Kim S.J., and Namkoong S.E. Physical status and expression of HPV genes in cervical cancers. Gynecol. Oncol. 65 (1997) 121-129
26. Praetorius F. HPV-associated diseases of oral mucosa. Clin. Dermatol. 15 (1997) 399-413
27. Rabah R., Lancaster W.D., Thomas R., and Gregoire L. Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatr. Dev. Pathol. 4 (2001) 68-72
28. Sano T., Oyama T., Kashiwabara K., Fukuda T., and Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am. J. Pathol. 153 (1998) 1741-1748
29. Schiffman M.H., Bauer H.M., Lorincz A.T., Manos M.M., Byrne J.C., Glass A.G., Cadell D.M., and Howley P.M. Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA. J. Clin. Microbiol. 29 (1991) 573-577
30. Schwartz S.M., Daling J.R., Doody D.R., Wipf G.C., Carter J.J., Madeleine M.M., Mao E.J., Fitzgibbons E.D., Huang S., Beckmann A.M., McDougall J.K., and Galloway D.A. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J. Natl. Cancer Inst. 90 (1998) 1626-1636
31. Serrano M., Hannon G.J., and Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366 (1993) 704-707
32. Smith E.M., Summersgill K.F., Allen J., Hoffman H.T., McCulloch T., Turek L.P., and Haugen T.H. Human papillomavirus and risk of laryngeal cancer. Ann. Otol. Rhinol. Laryngol. 109 (2000) 1069-1076
33. Smith E.M., Ritchie J.M., Summersgill K.F., Klussmann J.P., Lee J.H., Wang D., Haugen T.H., and Turek L.P. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int. J. Cancer 108 (2004) 766-772
34. Syrjänen S. Human papillomavirus (HPV) in head and neck cancer. J. Clin. Virol. 32 Suppl. 1 (2005) S59-S66
35. INK4. Cancer Res. 54 (1994) 5816-5820
36. Temam S., Benard J., Dugas C., Trassard M., Gormally E., Soria J.C., Faivre S., Luboinski B., Madaras P., Hainant P., Lenoir G., Mao L., and Janot F. Molecular detection of early-stage laryngopharyngeal squamous cell carcinomas. Clin. Cancer Res. 11 (2005) 2547-2551
37. Vernon S.D., Unger E.R., and Williams D. Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J. Clin. Microbiol. 38 (2000) 651-655
38. von Knebel Doeberitz M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infection. Eur. J. Cancer 38 (2002) 2229-2242
39. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999) 12-19